Two veterans from MPM have launched a new VC firm, Vie Ventures, that will focus on investing in the I&I space - and it will leverage collaborations with disease specific philanthropies

blonca9
2 days ago
1 min read

Co-Founders Luke Evnin and Steven St. Peter describe the idea behind the firm, the value in partnering with philanthropies who know these diseases best, and why I&I is going through such a revolution currently.

Recent Posts

See All

From London: Cancer Research Horizons takes research from Cancer Research UK (and beyond) and invests in the translational work and companies that turn it into cures

Jefferies London: Affinity Asset Advisors' Patrick Nosker shares a public investor's perspective on biotech and comments on a few of his firm's top positions

Jefferies London: Medicxi announced a €500 million Fund V ahead of this week's conference - Co-founder Giovanni Mariggi describes the firm's asset-centric approach to investing in biotech

Two veterans from MPM have launched a new VC firm, Vie Ventures, that will focus on investing in the I&I space - and it will leverage collaborations with disease specific philanthropies

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight